The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Briquilimab is a monoclonal antibody commercialized by Jasper Therapeutics, with a leading Phase II program in Severe Combined Immune Deficiency (SCID).

ORLANDO -- First-dose reactions to IV ustekinumab (Stelara) may be related to IgE recognition of a carbohydrate allergen in ...

GT Biopharma (NASDAQ:GTBP – Get Free Report) and Allakos (NASDAQ:ALLK – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies ...